Trinity Biotech Senior Executives to Attend ATTD 2026 to Advance Collaborations Following Strong Progress in CGM Program

Stock Information for Trinity Biotech plc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Trinity Biotech plc

Trinity Biotech Announces Collaboration with University at Buffalo to Commercialize Novel Biomarkers for Sjögren's Syndrome
Trinity Biotech Begins Rollout of Innovative Glucose Monitoring System In Key Market Following Regulatory Approval of Next-Generation Premier Hb9210 HbA1c Column System
Trinity Biotech Announces Further Major Technical Breakthroughs in Advancing Next Generation CGM+ Platform 
Trinity Biotech Provides Business and Trading Update
Trinity Biotech Secures $25 Million Financing Commitment to Support Growth Initiatives
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Nasdaq Minimum Bid Price Requirement
Trinity Biotech Secures Regulatory Approval for Commencement of Upstream Manufacturing Activities of Uni-Gold(TM) HIV Rapid Test Under Its Offshored and Outsourced Model, Supporting Financial Performance Transformation

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.